{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:08:44Z","timestamp":1792886924717,"version":"4.5.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"Importance<\/jats:title>Antihypertensive medication deprescribing is common among nursing home residents, yet its association with cognitive decline remains uncertain.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate the association of deprescribing antihypertensive medication with changes in cognitive function in nursing home residents.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study using a target trial emulation approach included VA long-term care residents aged 65 years or older with stays of at least 12 weeks from 2006 to 2019. Residents who were not prescribed antihypertensive medication, with blood pressure greater than 160\/90 mm Hg, or with heart failure were excluded. Eligible residents with stable medication use for 4 weeks were classified into deprescribing or stable user groups and followed for 2 years or until death or discharge for intention-to-treat (ITT) analysis. Participants switching treatment groups were censored in the per-protocol analysis. Cognitive function measurements during follow-up were analyzed using an ordinal generalized linear mixed model, adjusting for confounders with inverse probability of treatment weighting. Per-protocol analysis included inverse probability of censoring weighting. Data analyses were performed from May 1, 2023, and July 1, 2024.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Deprescribing was defined as a reduction in the total number of antihypertensive medications or a decrease in medication dosage by 30%, sustained for a minimum of 2 weeks.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Cognitive Function Scale (CFS) was classified as cognitively intact (CFS\u2009=\u20091), mildly impaired (CFS\u2009=\u20092), moderately impaired (CFS\u2009=\u20093), and severely impaired (CFS\u2009=\u20094).<\/jats:p><\/jats:sec>Results<\/jats:title>Of 45\u202f183 long-term care residents, 12 644 residents (mean [SD] age 77.7 [8.3] years; 329 [2.6%] females and 12 315 [97.4%] males) and 12 053 residents (mean [SD] age 77.7 [8.3] years; 314 [2.6%] females and 11 739 [97.4%] males) met eligibility for ITT and per-protocol analyses, respectively. At the end of the follow-up, 12.0% of residents had a worsened CFS (higher score) and 7.7% had an improved CFS (lower score) with 10.8% of the deprescribing group and 12.1% of the stable user group showing a worsened CFS score. In the per-protocol analysis, the deprescribing group had a 12% reduction in the odds of progressing to a worse CFS category per 12-week period (odds ratio, 0.88; 95% CI, 0.78-0.99) compared to the stable user group. Among residents with dementia, deprescribing was associated with 16% reduced odds of cognitive decline (odds ratio,\u20090.84; 95% CI, 0.72-0.98). These patterns remained consistent in the ITT analysis.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cohort study indicates that deprescribing is associated with less cognitive decline in nursing home residents, particularly those with dementia. More data are needed to understand the benefits and harms of antihypertensive deprescribing to inform patient-centered medication management in nursing homes.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamainternmed.2024.4851","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:32:16Z","timestamp":1727105536000},"page":"1347","source":"Crossref","is-referenced-by-count":32,"title":["Deprescribing of Antihypertensive Medications and Cognitive Function in Nursing Home Residents"],"prefix":"10.1001","volume":"184","author":[{"given":"Bocheng","family":"Jing","sequence":"first","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"},{"name":"Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, San Francisco, California"},{"name":"Northern California Institute for Research and Education, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Graham","sequence":"additional","affiliation":[{"name":"Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"},{"name":"Stanford-Surgery Policy Improvement Research and Education Center, Department of Surgery, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chintan V.","family":"Dave","sequence":"additional","affiliation":[{"name":"Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research; Rutgers University, New Brunswick, New Jersey"},{"name":"Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey"},{"name":"Department of Veterans Affairs, New Jersey Health Care System, East Orange, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Fung","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"},{"name":"Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine K.","family":"Liu","sequence":"additional","affiliation":[{"name":"Section of Geriatrics, Division of Primary Care and Population Health, Stanford University, School of Medicine, Stanford, California"},{"name":"Geriatric Research Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda S.","family":"Abdel Magid","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"},{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Growdon","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. James","family":"Deardorff","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Boscardin","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"},{"name":"Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, San Francisco, California"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"},{"name":"Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Steinman","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California, San Francisco"},{"name":"Geriatrics, Palliative, and Extended Care Service Line, San Francisco Veterans Affairs Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Odden","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California"},{"name":"Geriatric Research Education and Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"ioi240061r1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/jgs.16136","article-title":"Advancing the science of deprescribing: a novel comprehensive conceptual framework.","volume":"67","author":"Linsky","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"ioi240061r2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/jamainternmed.2019.7082","article-title":"Antihypertensive prescribing cascades as high-priority targets for deprescribing.","volume":"180","author":"Anderson","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"ioi240061r3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.117.032582","article-title":"Potential US population impact of the 2017 ACC\/AHA high blood pressure guideline.","volume":"137","author":"Muntner","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"ioi240061r4","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1111\/jgs.18301","article-title":"Systolic blood pressure, antihypertensive treatment, and cardiovascular and mortality risk in VA nursing home residents.","volume":"71","author":"Liu","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"ioi240061r5","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1111\/jgs.13153","article-title":"Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review.","volume":"62","author":"Fried","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"ioi240061r6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamainternmed.2014.8012","article-title":"Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study.","volume":"175","author":"Benetos","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"3","key":"ioi240061r7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/ajh\/hpx203","article-title":"Antihypertensive medications and falls in the elderly.","volume":"31","author":"Cai","year":"2018","journal-title":"Am J Hypertens"},{"issue":"10","key":"ioi240061r8","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00198-013-2369-7","article-title":"The risk of falls on initiation of antihypertensive drugs in the elderly.","volume":"24","author":"Butt","year":"2013","journal-title":"Osteoporos Int"},{"issue":"11","key":"ioi240061r9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11906-022-01215-3","article-title":"Antihypertensive deprescribing in older adults: A practical guide.","volume":"24","author":"Sheppard","year":"2022","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"ioi240061r10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice.","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"ioi240061r11","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.jamda.2019.01.130","article-title":"Deprescribing in nursing home residents on polypharmacy: incidence and associated factors.","volume":"20","author":"Onder","year":"2019","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"ioi240061r12","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1111\/jgs.16081","article-title":"Hypertension Treatment in US Long-Term Nursing Home Residents With and Without Dementia.","volume":"67","author":"Boockvar","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"ioi240061r13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.","volume":"71","author":"Gottesman","year":"2014","journal-title":"JAMA Neurol"},{"issue":"3","key":"ioi240061r14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/HYPERTENSIONAHA.122.20112","article-title":"Diastolic blood pressure and intensive blood pressure control on cognitive outcomes: insights from the SPRINT MIND Trial.","volume":"80","author":"Jiang","year":"2023","journal-title":"Hypertension"},{"issue":"19","key":"ioi240061r15","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis.","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"ioi240061r16","doi-asserted-by":"publisher","first-page":"e2134553","DOI":"10.1001\/jamanetworkopen.2021.34553","article-title":"Evaluation of intensive vs standard blood pressure reduction and association with cognitive decline and dementia: a systematic review and meta-analysis.","volume":"4","author":"Dallaire-Th\u00e9roux","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"ioi240061r17","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1097\/HJH.0000000000002102","article-title":"The role of functional status on the relationship between blood pressure and cognitive decline: the Cardiovascular Health Study.","volume":"37","author":"Miller","year":"2019","journal-title":"J Hypertens"},{"issue":"9","key":"ioi240061r18","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1111\/jgs.13616","article-title":"Age- and Functional Status-Dependent Association Between Blood Pressure and Cognition: The Milan Geriatrics 75+ Cohort Study.","volume":"63","author":"Ogliari","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"ioi240061r19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/jamainternmed.2014.8164","article-title":"Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.","volume":"175","author":"Mossello","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"11","key":"ioi240061r20","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/j.1532-5415.2012.04203.x","article-title":"High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study.","volume":"60","author":"Sabayan","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"ioi240061r21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/HYPERTENSIONAHA.117.09336","article-title":"Should hypertension be treated in late life to preserve cognitive function? Con side of the argument.","volume":"71","author":"Gottesman","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"ioi240061r22","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","article-title":"Impact of hypertension on cognitive function: a scientific statement from the American Heart Association.","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"issue":"7404","key":"ioi240061r23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"ioi240061r24","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1097\/MLR.0000000000000334","article-title":"The minimum data set 3.0 cognitive function scale.","volume":"55","author":"Thomas","year":"2017","journal-title":"Med Care"},{"issue":"1","key":"ioi240061r25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jgs.18052","article-title":"Development and validation of novel multimorbidity indices for older adults.","volume":"71","author":"Steinman","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"26","key":"ioi240061r27","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1002\/sim.5866","article-title":"An assessment of estimation methods for generalized linear mixed models with binary outcomes.","volume":"32","author":"Capanu","year":"2013","journal-title":"Stat Med"},{"issue":"5","key":"ioi240061r28","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Website and R package for computing E-values.","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"issue":"4","key":"ioi240061r29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"25","key":"ioi240061r30","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"24","key":"ioi240061r31","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1212\/WNL.0000000000000517","article-title":"Joint effect of mid- and late-life blood pressure on the brain: the AGES-Reykjavik study.","volume":"82","author":"Muller","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"ioi240061r32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2019.10575","article-title":"Association of midlife to late-life blood pressure patterns with incident dementia.","volume":"322","author":"Walker","year":"2019","journal-title":"JAMA"},{"issue":"20","key":"ioi240061r33","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/jama.2020.4871","article-title":"Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE randomized clinical trial.","volume":"323","author":"Sheppard","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"ioi240061r34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12916-017-0988-0","article-title":"Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice-the ECSTATIC study: a cluster randomised non-inferiority trial.","volume":"16","author":"Luymes","year":"2018","journal-title":"BMC Med"},{"issue":"10","key":"ioi240061r35","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1001\/jamainternmed.2015.4103","article-title":"Effect of discontinuation of antihypertensive treatment in elderly people on cognitive functioning\u2014the DANTE Study Leiden: a randomized clinical trial.","volume":"175","author":"Moonen","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"10","key":"ioi240061r36","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities (ARIC) cohort.","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"key":"ioi240061r37","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18829","article-title":"Evaluation of medical therapies in the nursing home population: gaps, challenges, and next steps.","author":"Unroe","year":"2024","journal-title":"J Am Geriatr Soc"},{"issue":"16","key":"ioi240061r38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jama.2023.4221","article-title":"Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials.","volume":"329","author":"Wang","year":"2023","journal-title":"JAMA"},{"key":"ioi240061r26","volume-title":"Applied longitudinal analysis","author":"Fitzmaurice","year":"2012"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2823919\/jamainternal_jing_2024_oi_240061_1729873825.38161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:01:31Z","timestamp":1730736091000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2823919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2024.4851","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,1]]}}}